Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cavitation Technologies (CVAT) Current Deferred Revenue (2017 - 2024)

Cavitation Technologies' Current Deferred Revenue history spans 11 years, with the latest figure at $382000.0 for Q1 2024.

  • For Q1 2024, Current Deferred Revenue fell 13.77% year-over-year to $382000.0; the TTM value through Mar 2024 reached $382000.0, down 13.77%, while the annual FY2023 figure was $391000.0, 388.75% up from the prior year.
  • Current Deferred Revenue for Q1 2024 was $382000.0 at Cavitation Technologies, down from $555000.0 in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $1.0 million in Q1 2022 and bottomed at $36000.0 in Q3 2022.
  • The 5-year median for Current Deferred Revenue is $474500.0 (2020), against an average of $521812.5.
  • The largest annual shift saw Current Deferred Revenue crashed 96.25% in 2022 before it surged 1830.56% in 2023.
  • A 5-year view of Current Deferred Revenue shows it stood at $506000.0 in 2020, then soared by 89.53% to $959000.0 in 2021, then tumbled by 73.2% to $257000.0 in 2022, then skyrocketed by 115.95% to $555000.0 in 2023, then plummeted by 31.17% to $382000.0 in 2024.
  • Per Business Quant, the three most recent readings for CVAT's Current Deferred Revenue are $382000.0 (Q1 2024), $555000.0 (Q4 2023), and $695000.0 (Q3 2023).